Document is current

Any future updates will be listed below

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Crossref DOI link: https://doi.org/10.1186/s40880-019-0384-6

Published Online: 2019-06-24

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

About CrossMark